Business
CSL rules out making homegrown mRNA COVID vaccine – Sydney Morning Herald
The local biotech giant’s boss, Paul Perreault, says mRNA technology will be used to develop a treatment against flu instead…
The Australian Shareholders Association also whether the board had considered intervening in Mr Perreaults 2021 pay, after he received $61 million in total remuneration last year despite total shareholder return being zero. Mr McNamee said this total came…
Continue Reading
-
Noosa News22 hours agoTeachers strike looms as thousands prepare to walk off the job next Wednesday in Queensland
-
Noosa News23 hours agoHandmade + Plant-Based Market – Concrete Playground
-
Business23 hours ago5 high-quality ASX ETFs to buy in August
-
General22 hours agoNation urged to increase spending on AI storage